Neil S. Holden

2.1k total citations
31 papers, 1.6k citations indexed

About

Neil S. Holden is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Neil S. Holden has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Neil S. Holden's work include NF-κB Signaling Pathways (11 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Immune Response and Inflammation (8 papers). Neil S. Holden is often cited by papers focused on NF-κB Signaling Pathways (11 papers), Cytokine Signaling Pathways and Interactions (10 papers) and Immune Response and Inflammation (8 papers). Neil S. Holden collaborates with scholars based in Canada, United Kingdom and United States. Neil S. Holden's co-authors include Robert Newton, Christopher F. Rider, Elizabeth M. King, Peter J. Barnes, Matthew C. Catley, Wei Gong, Manminder Kaur, Richard Leigh, David Proud and Mark A. Giembycz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Neil S. Holden

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neil S. Holden Canada	25	582	523	499	325	313	31	1.6k
Matthew C. Catley United Kingdom	24	698 1.2×	556 1.1×	416 0.8×	324 1.0×	379 1.2×	36	1.7k
Gye Young Park United States	23	608 1.0×	689 1.3×	316 0.6×	271 0.8×	243 0.8×	55	1.6k
Deborah Clarke United Kingdom	22	444 0.8×	591 1.1×	500 1.0×	551 1.7×	207 0.7×	32	1.7k
Dong-Hong Zhang United States	14	496 0.9×	1.4k 2.7×	713 1.4×	187 0.6×	290 0.9×	17	2.2k
Soo‐Cheon Chae South Korea	26	1.1k 1.8×	738 1.4×	380 0.8×	107 0.3×	283 0.9×	106	2.4k
Carlos Hernández Spain	24	697 1.2×	465 0.9×	293 0.6×	155 0.5×	281 0.9×	56	1.9k
Suchita Nadkarni United Kingdom	19	636 1.1×	904 1.7×	175 0.4×	151 0.5×	235 0.8×	41	2.0k
Anastasia Sobolewski United Kingdom	14	472 0.8×	439 0.8×	179 0.4×	255 0.8×	375 1.2×	21	1.5k
Bing-Chang Chen Taiwan	24	711 1.2×	311 0.6×	193 0.4×	236 0.7×	232 0.7×	44	1.5k
Stephen A. Stimpson United States	27	1000 1.7×	530 1.0×	425 0.9×	98 0.3×	295 0.9×	40	2.4k

Countries citing papers authored by Neil S. Holden

Since Specialization

Citations

This map shows the geographic impact of Neil S. Holden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil S. Holden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil S. Holden more than expected).

Fields of papers citing papers by Neil S. Holden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil S. Holden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil S. Holden. The network helps show where Neil S. Holden may publish in the future.

Co-authorship network of co-authors of Neil S. Holden

This figure shows the co-authorship network connecting the top 25 collaborators of Neil S. Holden. A scholar is included among the top collaborators of Neil S. Holden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil S. Holden. Neil S. Holden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gittins, Matthew, Christopher Ashton, Neil S. Holden, et al.. (2020). Environmental Factors and Hyperacute Stroke Care Activity During the COVID-19 Pandemic: An Interrupted Time-Series Analysis. Journal of Stroke and Cerebrovascular Diseases. 29(11). 105229–105229. 8 indexed citations

Holden, Neil S., Suzanne Traves, Shahina Wiehler, et al.. (2017). Human Rhinovirus Infection of Epithelial Cells Modulates Airway Smooth Muscle Migration. American Journal of Respiratory Cell and Molecular Biology. 56(6). 796–803. 31 indexed citations

Holden, Neil S., Christopher F. Rider, Elizabeth M. King, et al.. (2011). β ₂ -Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proceedings of the National Academy of Sciences. 108(49). 19713–19718. 69 indexed citations

Rider, Christopher F., Elizabeth M. King, Neil S. Holden, Mark A. Giembycz, & Robert Newton. (2011). Inflammatory Stimuli Inhibit Glucocorticoid-Dependent Transactivation in Human Pulmonary Epithelial Cells: Rescue by Long-Acting β2-Adrenoceptor Agonists. Journal of Pharmacology and Experimental Therapeutics. 338(3). 860–869. 50 indexed citations

Holden, Neil S., et al.. (2010). Principles and problems of the electrophoretic mobility shift assay. Journal of Pharmacological and Toxicological Methods. 63(1). 7–14. 43 indexed citations

Holden, Neil S., Christopher F. Rider, M. J. Bell, et al.. (2010). Enhancement of inflammatory mediator release by β₂‐adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. British Journal of Pharmacology. 160(2). 410–420. 37 indexed citations

Newton, Robert, Wei Gong, Christopher F. Rider, et al.. (2010). Glucocorticoids inhibit IL-1β-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1. Biochemical Journal. 427(1). 113–124. 41 indexed citations

Zaheer, Raza S., et al.. (2009). Selective Transcriptional Down-Regulation of Human Rhinovirus-Induced Production of CXCL10 from Airway Epithelial Cells via the MEK1 Pathway. The Journal of Immunology. 182(8). 4854–4864. 35 indexed citations

King, Elizabeth M., Neil S. Holden, Wei Gong, Christopher F. Rider, & Robert Newton. (2009). Inhibition of NF-κB-dependent Transcription by MKP-1. Journal of Biological Chemistry. 284(39). 26803–26815. 114 indexed citations

10.

Wiehler, Shahina, et al.. (2009). Human Rhinovirus Infection Up-Regulates MMP-9 Production in Airway Epithelial Cells via NF-κB. American Journal of Respiratory Cell and Molecular Biology. 43(2). 201–209. 57 indexed citations

11.

Kaur, Manminder, Neil S. Holden, Sylvia M. Wilson, et al.. (2008). Effect of β₂-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. American Journal of Physiology-Lung Cellular and Molecular Physiology. 295(3). L505–L514. 55 indexed citations

12.

Zaheer, Raza S., et al.. (2008). Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells. Journal of Allergy and Clinical Immunology. 123(1). 201–208.e9. 41 indexed citations

13.

Holden, Neil S., et al.. (2007). Determinants of the Lapse Rate in Life Insurance Operating Companies. 28(1). 54. 4 indexed citations

14.

Newton, Robert, Neil S. Holden, Matthew C. Catley, et al.. (2007). Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule IκB Kinase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 321(2). 734–742. 86 indexed citations

15.

Chivers, Joanna E., Wei Gong, Elizabeth M. King, et al.. (2006). Analysis of the Dissociated Steroid RU24858 Does Not Exclude a Role for Inducible Genes in the Anti-Inflammatory Actions of Glucocorticoids. Molecular Pharmacology. 70(6). 2084–2095. 63 indexed citations

16.

Newton, Robert & Neil S. Holden. (2006). New aspects of p38 mitogen activated protein kinase (MAPK) biology in lung inflammation. Drug Discovery Today Disease Mechanisms. 3(1). 53–61. 11 indexed citations

17.

Catley, Matthew C., Joanna E. Chivers, Neil S. Holden, Peter J. Barnes, & Robert Newton. (2005). Validation of IKKβ as therapeutic target in airway inflammatory disease by adenoviral‐mediated delivery of dominant‐negative IKKβ to pulmonary epithelial cells. British Journal of Pharmacology. 145(1). 114–122. 36 indexed citations

18.

Holden, Neil S., Matthew C. Catley, Lisa Cambridge, Peter J. Barnes, & Robert Newton. (2004). ICAM‐1 expression is highly NF‐κB‐dependent in A549 cells. European Journal of Biochemistry. 271(4). 785–791. 48 indexed citations

19.

Catley, Matthew C., Joanna E. Chivers, Lisa Cambridge, et al.. (2003). IL‐1β‐dependent activation of NF‐κB mediates PGE₂ release via the expression of cyclooxygenase‐2 and microsomal prostaglandin E synthase. FEBS Letters. 547(1-3). 75–79. 87 indexed citations

20.

Newton, Robert & Neil S. Holden. (2003). Inhibitors of p38 Mitogen-Activated Protein Kinase. BioDrugs. 17(2). 113–129. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact